Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
89zr df-iab2m (4 trials)
azd8853 (1 trial)
iab22m2c (7 trials)
asp8374 (1 trial)
bempegaldesleukin (1 trial)
cemiplimab (libtayo) (1 trial)
nivolumab (opdivo) (1 trial)
124i-psca (1 trial)
Hodgkin Disease (Phase 1)
Lymphoma (Phase 1)
Neoplasms (Phase 1)
Prostatic Neoplasms (Phase 2)
Trials (12 total)
Trial APIs (8 total)